Investing
Cathie Wood's ARK Invest Buys Over 530,000 Shares of Fate Therapeutics
Published:
One of the ARK Invest exchange-traded funds run by ETF star Cathie Wood made a sizable purchase on Wednesday. The fund bought over 530,000 shares of Fate Therapeutics Inc. (NASDAQ: FATE), as the price of this ETF was down over 2% on the day. Note that this fund is up significantly in the past year.
Specifically, ARK Innovation ETF (NYSEARCA: ARKK) bought 535,305 shares of Fate Therapeutics. At Wednesday’s closing price, this would have valued this purchase at roughly $46.2 million. Even though this is a small fraction of the total holdings, every little bit counts. The fund is up 60% in the past year.
Here’s a look at the other purchases across the ARK ETFs:
| Fund | Ticker | Company | Shares |
|---|---|---|---|
| ARKF | PATH | UiPath | 279,284 |
| ARKG | SGFY | Signify Health | 53,916 |
| ARKG | RXRX | Recursion Pharmaceuticals | 204,752 |
| ARKG | RPTX | Repare Therapeutics | 18,190 |
| ARKG | QSI | Quantum-Si | 359,389 |
| ARKG | MASS | 908 Devices | 47,945 |
| ARKK | FATE | Fate Therapeutics | 535,305 |
| ARKK | COIN | Coinbase Global | 20,165 |
| ARKK | TSLA | Tesla | 110,731 |
| ARKQ | PATH | UiPath | 135,228 |
| ARKW | VUZI | Vuzix | 521,151 |
| ARKW | FTCH | Farfetch | 599,955 |
| ARKX | AVAV | Aerovironment | 23,098 |
| ARKX | PATH | UiPath | 25,645 |
Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St.
24/7 Wall St.Want to Retire Early? Start Here (Sponsor)
Want retirement to come a few years earlier than you’d planned? Or are you ready to retire now, but want an extra set of eyes on your finances?
Now you can speak with up to 3 financial experts in your area for FREE. By simply clicking here you can begin to match with financial professionals who can help you build your plan to retire early. And the best part? The first conversation with them is free.
Click here to match with up to 3 financial pros who would be excited to help you make financial decisions.
Have questions about retirement or personal finance? Email us at [email protected]!
By emailing your questions to 24/7 Wall St., you agree to have them published anonymously on a673b.bigscoots-temp.com.
By submitting your story, you understand and agree that we may use your story, or versions of it, in all media and platforms, including via third parties.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
